← Leaderboards
Amy J Davidoff
University Of Maryland Baltimore
$1,144,928
Attributed
$1,144,928
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $616.7K · FY2009–10$1M$750K$500K$250K$0
'09
'10
Funding mix
By agency
NIH$1,144,928 · 2
By mechanism
RC1$773,678 · 1
R21$371,250 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Braxton D Mitchell$18,150,115
- Carol A. Tamminga$26,097,596
- Claudia Rose Baquet$15,865,421
- Peixin Yang$21,969,416
- Charles S. Via$4,008,652
Others in their field
Top investigators on “Insurance”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Helen M Berman · Rutgers University New Brunswick$62,129,822
- Bruce J Hillman · American College Of Radiology$58,852,329
- Daniel Ernest Ford · Johns Hopkins University$57,376,797
- Arie Kapteyn · Rand Corporation$56,339,826
Research focus
InsuranceOncologistEffectiveness ResearchHealth StatusMedicareNeoplasm RegistryComparative EffectivenessData SourcesElderlyEnrollmentLinkMalignant NeoplasmsMedicare ClaimBeneficiaryCharacteristicsClinical TrialsCostData SetCancer PatientCancer TherapyCaringApplications GrantsAffectPattern
Grant awards (4)
Comparative Effectiveness: Erythropoietic Stimulating Agents in Treatment of MDS$447,924
RC1 · FY2010 · CA · contact PI
Patient performance status: prediction model development and validation$168,750
R21 · FY2010 · CA · contact PI
Comparative Effectiveness: Erythropoietic Stimulating Agents in Treatment of MDS$325,754
RC1 · FY2009 · CA · contact PI
Patient performance status: prediction model development and validation$202,500
R21 · FY2009 · CA · contact PI